Resource Logo

South African government abandons AZT pilot project.


AIDS Alert. 1998 Dec;13(12):suppl 1-2. Unique Identifier : AIDSLINE

The South African government called an abrupt halt to a pilot project that was testing short-course Zidovudine (AZT) prophylaxis treatment designed to prevent mother-to-child HIV transmission. Health Minister Nkosazana Zuma says the $14 million needed for the program would be more effective if spent on prevention programs. However, studies have shown that AZT treatment, along with breast-milk substitutes, and HIV testing and counseling are cost effective and can prevent HIV transmission. There has not been an outcry among patients, as many of them have not publicly disclosed their HIV status and therefore are reluctant to express their anger.

NEWSLETTER ARTICLE Anti-HIV Agents/*THERAPEUTIC USE Cost-Benefit Analysis Disease Transmission, Vertical/*PREVENTION & CONTROL Female HIV Infections/EPIDEMIOLOGY/*PREVENTION & CONTROL/TRANSMISSION Health Policy/*ECONOMICS Human Infant, Newborn Pilot Projects Pregnancy Pregnancy Complications, Infectious/DRUG THERAPY Prenatal Care South Africa/EPIDEMIOLOGY Zidovudine/*THERAPEUTIC USE


Information in this article was accurate in December 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.